UCSF, UCLA gain FDA approval for prostate cancer imaging technique December 6, 2020 The University of California’s two nationally ranked medical centers, UC San Francisco and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.Read the full article here. Source: Duane Bates,Elizabeth Fernandez - UCSF.edu About Prostate Cancer Imaging Prostate Cancer News More for you
The University of California’s two nationally ranked medical centers, UC San Francisco and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.Read the full article here. Source: Duane Bates,Elizabeth Fernandez - UCSF.edu
